Literature DB >> 18446686

Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes.

M Kuzmicki1, B Telejko, A Zonenberg, J Szamatowicz, A Kretowski, A Nikolajuk, P Laudanski, M Gorska.   

Abstract

In this study we measured serum concentrations of proinflammatory interleukin-6, interleukin-8, and interleukin-18 as well as anti-inflammatory interleukin-10 in 30 pregnant women with normal glucose tolerance, in 32 women with abnormal results of a 50-g glucose challenge test, and in 57 patients with gestational diabetes mellitus. Patients with gestational diabetes had significantly higher IL-6 (median 1.0 [0.7-1.5] vs. 0.7 [0.4-0.8] pg/ml, p=0.001), IL-8 (2.1 [1.1-4.2] pg/ml vs. 0.7 [0.4-0.9] pg/ml, p<0.0001), and IL-18 (249.3 [188.5-318.7] pg/ml vs. 186.7 [139.9-243.9] pg/ml, p=0.005) as well as lower IL-10 levels than healthy pregnant women (0.6 [0.5-1.5] pg/ml vs. 2.9 [1.8-3.2] pg/ml, p<0.0001). After adjusting for glucose, insulin, and BMI values, the differences in IL-8 and IL-18 became insignificant, whereas the differences in IL-6 and IL-10 levels remained highly significant (p<0.0001). The subjects with abnormal glucose challenge test results had higher IL-6 levels (0.9 [0.7-1.3] pg/ml, p=0.005) and similar levels of other cytokines as compared with the women with normal glucose tolerance. Our results suggest an impaired balance between circulating pro- and anti-inflammatory cytokines in patients with gestational diabetes; however, a significant contribution of maternal obesity to the increased levels of IL-8 and IL-18 should be underlined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446686     DOI: 10.1055/s-2008-1073166

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  19 in total

Review 1.  Inflammation in maternal obesity and gestational diabetes mellitus.

Authors:  P Pantham; I L M H Aye; T L Powell
Journal:  Placenta       Date:  2015-04-28       Impact factor: 3.481

Review 2.  Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.

Authors:  Tove Lekva; Errol R Norwitz; Pål Aukrust; Thor Ueland
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

3.  Roles of Inflammation and Depression in the Development of Gestational Diabetes.

Authors:  Thalia K Robakis; Linn Aasly; Katherine Ellie Williams; Claire Clark; Natalie Rasgon
Journal:  Curr Behav Neurosci Rep       Date:  2017-10-28

4.  Gestational diabetes mellitus is associated with increased CD163 expression and iron storage in the placenta.

Authors:  Theresa L Barke; Jeffery A Goldstein; Alexandra C Sundermann; Arun P Reddy; Jodell E Linder; Hernan Correa; Digna R Velez-Edwards; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2018-07-09       Impact factor: 3.886

5.  Second trimester maternal plasma levels of cytokines IL-1Ra, Il-6 and IL-10 and preterm birth.

Authors:  R J Ruiz; N Jallo; C Murphey; C N Marti; E Godbold; R H Pickler
Journal:  J Perinatol       Date:  2012-03-29       Impact factor: 2.521

6.  Omentin-1 and its relationship with inflammatory factors in maternal plasma and visceral adipose tissue of women with gestational diabetes mellitus.

Authors:  M I Peña-Cano; J Valencia-Ortega; E Morales-Ávila; M F Díaz-Velázquez; R Gómez-Díaz; R Saucedo
Journal:  J Endocrinol Invest       Date:  2021-09-04       Impact factor: 4.256

7.  Childhood maltreatment and inflammation among pregnant women with gestational diabetes mellitus: A pilot study.

Authors:  Margaret Bublitz; Suzanne De La Monte; Susan Martin; Lucia Larson; Ghada Bourjeily
Journal:  Obstet Med       Date:  2017-05-10

8.  Peripartum complications associated with obsessive compulsive disorder exacerbation during pregnancy.

Authors:  Calliope Holingue; Jack Samuels; Valeria Guglielmi; Wendy Ingram; Gerald Nestadt; Paul S Nestadt
Journal:  J Obsessive Compuls Relat Disord       Date:  2021-03-22       Impact factor: 1.677

9.  Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.

Authors:  Karol Charkiewicz; Agnieszka Blachnio-Zabielska; Monika Zbucka-Kretowska; Slawomir Wolczynski; Piotr Laudanski
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

10.  Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome.

Authors:  Piotr Laudanski; Monika Zbucka-Kretowska; Karol Charkiewicz; Slawomir Wolczynski; Daniela Wojcik; Radoslaw Charkiewicz
Journal:  Mediators Inflamm       Date:  2014-11-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.